The North America Amniocentesis Needle Market would witness market growth of 6.1% CAGR during the forecast period (2023-2030).
Manufacturers focus on developing smaller, thinner, and more precise amniocentesis needles to enhance patient comfort, minimize tissue trauma, and improve procedural outcomes. Needle design innovations, such as ultrafine tips, ergonomic handles, and enhanced visualization features, are increasingly prevalent to facilitate safe and accurate fluid extraction during amniocentesis procedures.
The integration of imaging technologies, such as ultrasound and fluoroscopy, into amniocentesis procedures, is gaining traction to improve needle placement accuracy, enhance visualization of fetal anatomy, and reduce procedural risks. Real-time imaging guidance allows healthcare providers to navigate needle insertion more effectively and ensure optimal positioning within the amniotic sac, contributing to enhanced procedural safety and efficacy.
According to the International Trade Administration (ITA), in 2022, Canada's medical device industry size was estimated to be US$6.8 billion. The medical device industry is expected to grow 5.4% annually until 2028. In 2022, healthcare spending in Canada totalled approximately C$331 billion or C$8563 per Canadian. Moreover, the rising prevalence of genetic disorders among the Mexican population has heightened awareness among expectant parents about the importance of prenatal testing. Hence, the expanding medical device sector and growing genetic disorders in the region are propelling the growth of the market.
The US market dominated the North America Amniocentesis Needle Market, by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $68596.6 Million by 2030. The Canada market is experiencing a CAGR of 8.5% during (2023 - 2030). Additionally, The Mexico market would exhibit a CAGR of 7.6% during (2023 - 2030).
Based on Procedure, the market is segmented into Amniocentesis Procedures, Fetal Blood Transfusion, Amnioreduction Procedures, Amnioinfusion Procedure, and Cordocentesis Procedure. Based on End-use, the market is segmented into Hospitals, Diagnostics centers, Clinics, and Others. Based on Type, the market is segmented into 100 to 150 mm, Larger Than 150 mm, and Smaller Than 100 mm. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Manufacturers focus on developing smaller, thinner, and more precise amniocentesis needles to enhance patient comfort, minimize tissue trauma, and improve procedural outcomes. Needle design innovations, such as ultrafine tips, ergonomic handles, and enhanced visualization features, are increasingly prevalent to facilitate safe and accurate fluid extraction during amniocentesis procedures.
The integration of imaging technologies, such as ultrasound and fluoroscopy, into amniocentesis procedures, is gaining traction to improve needle placement accuracy, enhance visualization of fetal anatomy, and reduce procedural risks. Real-time imaging guidance allows healthcare providers to navigate needle insertion more effectively and ensure optimal positioning within the amniotic sac, contributing to enhanced procedural safety and efficacy.
According to the International Trade Administration (ITA), in 2022, Canada's medical device industry size was estimated to be US$6.8 billion. The medical device industry is expected to grow 5.4% annually until 2028. In 2022, healthcare spending in Canada totalled approximately C$331 billion or C$8563 per Canadian. Moreover, the rising prevalence of genetic disorders among the Mexican population has heightened awareness among expectant parents about the importance of prenatal testing. Hence, the expanding medical device sector and growing genetic disorders in the region are propelling the growth of the market.
The US market dominated the North America Amniocentesis Needle Market, by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $68596.6 Million by 2030. The Canada market is experiencing a CAGR of 8.5% during (2023 - 2030). Additionally, The Mexico market would exhibit a CAGR of 7.6% during (2023 - 2030).
Based on Procedure, the market is segmented into Amniocentesis Procedures, Fetal Blood Transfusion, Amnioreduction Procedures, Amnioinfusion Procedure, and Cordocentesis Procedure. Based on End-use, the market is segmented into Hospitals, Diagnostics centers, Clinics, and Others. Based on Type, the market is segmented into 100 to 150 mm, Larger Than 150 mm, and Smaller Than 100 mm. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
List of Key Companies Profiled
- BIOPSYBELL S.R.L.
- Cook Medical, Inc. (Cook Group)
- Ri.Mos. Srl
- CooperSurgical, Inc. (The Cooper Companies, Inc.)
- Rocket Medical plc (Röko AB)
- Argon Medical Devices, Inc. (SHANDONG WEIGAO GROUP MEDICAL POLYMER COMPANY LIMITED)
- Moller Medical GmbH (Centrotec SE)
- Becton, Dickinson and Company
Market Report Segmentation
By Procedure- Amniocentesis Procedures
- Fetal Blood Transfusion
- Amnioreduction Procedures
- Amnioinfusion Procedure
- Cordocentesis Procedure
- Hospitals
- Diagnostics centers
- Clinics
- Others
- 100 to 150 mm
- Larger Than 150 mm
- Smaller Than 100 mm
- US
- Canada
- Mexico
- Rest of North America
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. North America Amniocentesis Needle Market, by Procedure
Chapter 5. North America Amniocentesis Needle Market, by End-use
Chapter 6. North America Amniocentesis Needle Market, by Type
Chapter 7. North America Amniocentesis Needle Market, by Country
Chapter 8. Company Profiles
Companies Mentioned
- BIOPSYBELL S.R.L.
- Cook Medical, Inc. (Cook Group)
- Ri.Mos. Srl
- CooperSurgical, Inc. (The Cooper Companies, Inc.)
- Rocket Medical plc (Röko AB)
- Argon Medical Devices, Inc. (SHANDONG WEIGAO GROUP MEDICAL POLYMER COMPANY LIMITED)
- Moller Medical GmbH (Centrotec SE)
- Becton, Dickinson and Company
Methodology
LOADING...
